Glen Mills, PA, United States of America

Patricia A Messina McLaughlin



Average Co-Inventor Count = 11.0

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2011-2016

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations of Patricia A Messina McLaughlin

Introduction

Patricia A Messina McLaughlin is a notable inventor based in Glen Mills, Pennsylvania. She has made significant contributions to the field of biochemistry, particularly in the development of proteasome inhibitors. With a total of four patents to her name, her work has implications for treating various diseases, including cancer.

Latest Patents

Among her latest patents, one notable invention is focused on proteasome inhibitors and methods of using the same. This invention provides boronic acid compounds, boronic esters, and compositions that can modulate apoptosis by inhibiting proteasome activity. These compounds and compositions are designed to be used in methods of inducing apoptosis and treating diseases associated with proteasome activity.

Career Highlights

Throughout her career, Patricia has worked with prominent companies in the pharmaceutical industry, including Cephalon, Inc. and Millennium Pharmaceuticals Limited. Her experience in these organizations has allowed her to contribute to significant advancements in drug development and therapeutic methods.

Collaborations

Patricia has collaborated with various professionals in her field, including Raffaella Bernardini and Alberto Bernareggi. These collaborations have further enriched her research and development efforts.

Conclusion

Patricia A Messina McLaughlin's innovative work in the field of proteasome inhibitors showcases her dedication to advancing medical science. Her contributions have the potential to impact the treatment of serious diseases, highlighting the importance of her inventions in the pharmaceutical landscape.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…